Username or EmailPassword
That's part of the problem right there; comparing software to pharmaceuticals. Software, which has a very high rate of evolution and very low costs to develop and implement, if it deserves patent protection at all, should not have the same term of protection as pharmaceuticals with a comparatively low rate of evolution and very high costs to develop and implement.
Show me several years of development, testing and FDA approval prior to general use of bounce-back affect at the end of a scrolling screen or similar bullshit patents and it'll maybe make a little more sense to talk about the half-decade protection rackets being granted on mathematics and business processes. Edited 2012-07-10 13:00 UTC